Conflating the patent-protected status of medicines plus the spectacularly expensive FDA approval process, with a “market”, does not a powerful argument make...

Conflating the patent-protected status of medicines plus the spectacularly expensive FDA approval process, with a “market”, does not a powerful argument make... Don’t get me wrong. There may or may not be a bunch of things wrong with the highly regulated (read: lobbiest controlled) and inefficient (almost insurmountable barriers to entry) medical industry — but using that as an argument against “markets” in general? Weak.